Treatment of Hormone Refractory Prostate Cancer with Quadramet and Taxotere

Armen Hareyan's picture

Treatment of Advanced Prostate Cancer

According to a press release from the Cytogen Corporation, treatment of advanced, hormone refractory prostate cancer with the chemotherapy drug Taxotere

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.